Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients

Stopped Study revised to use a different study medication and patient population.

Conditions

• Mild Cognitive Disorder
• Mild Cognitive Impairment

Interventions

• DRUG: Exelon [rivastigmine] transdermal patch
• DRUG: Placebo transdermal patch

Sponsor

The Cleveland Clinic